Skip to main content
NVDA-2.56%AAPL+2.09%GOOGL-0.15%MSFT+0.01%AMZN+0.07%TSM-1.00%SPCX+1.78%AVGO+0.04%META+0.01%TSLA-0.58%SKHY-4.03%MU-4.48%BRK-B-0.15%LLY+0.70%JPM-0.44%AMD-2.55%WMT+0.12%V-0.15%XOM+0.11%ASMLa-1.82%JNJ-0.04%INTC-4.41%MA-0.47%0700.HK-1.94%ORCL-2.24%1398.HK+0.79%BAC-0.50%ABBV+0.55%CSCO-0.53%CVX-0.46%COST+0.03%LRCX-3.93%KO+0.97%CAT-1.09%AMAT-2.32%0005.HK-0.78%AP2d-1.57%UNH-0.67%DELL-2.77%HSBA.L-1.17%MS-0.21%PG-0.22%GE-0.11%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.11%HD-0.96%GS-0.39%0939.HK+1.66%NZDJPY-2.69%AUDJPY-1.94%CHFJPY-1.66%USDJPY-1.50%NZDCAD-1.38%GBPJPY-1.38%EURJPY-1.37%EURNZD+1.37%CADJPY-1.32%GBPNZD+1.32%NZDUSD-1.22%NZDCHF-1.06%USDNOK+0.91%EURNOK+0.88%CHFNOK+0.80%AUDNZD+0.78%USDZAR+0.76%EURZAR+0.73%USDSEK+0.70%NOKJPY-0.68%EURSEK+0.66%GBPZAR+0.66%AUDCAD-0.65%AUDDKK-0.62%CHFSEK+0.59%EURAUD+0.58%GBPAUD+0.54%AUDSGD-0.49%USDMXN+0.46%AUDUSD-0.45%USDTHB+0.45%GBPTRY+0.41%NZDSGD-0.33%GBPHKD+0.32%CADCHF+0.32%AUDCHF-0.29%GBPMXN-0.28%EURCHF+0.28%AUDNOK+0.26%GBPCHF+0.26%USDPLN+0.25%EURPLN+0.21%USDCAD-0.17%USDCHF+0.17%USDILS+0.16%USDSGD+0.16%EURUSD+0.13%EURSGD+0.12%GBPUSD+0.11%USDTRY+0.11%EURCZK-0.08%GBPCAD-0.08%SGDJPY+0.08%USDCNH+0.06%NZDMXN-0.05%EURHKD-0.05%EURCAD-0.05%CHFSGD+0.04%EURCNH+0.04%USDCOP-0.04%EURGBP+0.04%USDDKK+0.04%GBPSGD+0.03%PLNJPY-0.01%USDHKD+0.01%EURDKK0.00%XPTUSD-4.93%HG1-4.65%GAGUSD-4.13%XAGUSD-4.13%UKOIL+3.72%USOIL+3.33%SUGAR+1.74%COCOA+1.05%GAUUSD-0.89%XAUUSD-0.89%S1+0.76%COTTON+0.71%BTCUSD-1.46%ETHUSD-1.30%USDTUSD-0.02%XRPUSD-2.93%SOLUSD-1.81%TRXUSDT-0.03%ZECUSDT-6.32%DOGEUSD-3.23%XMRUSDT-2.05%LINKUSD-1.53%XLMUSD-2.24%BCHUSDT-11.18%LTCUSD-2.07%UNIUSD-3.99%TONUSD+24.88%HBARUSDT-2.10%SUIUSD-3.84%TAOUSDT-5.84%AAVEUSD-3.26%DOTUSDT-3.07%ICPUSDT-1.15%ONDOUSDT-3.26%WLDUSDT-3.39%ATOMUSDT-4.43%ARBUSDT+0.43%JUPUSDT-3.82%INJUSDT-5.31%STXUSDT-3.80%FETUSDT-4.15%TIAUSDT-1.39%PYTHUSDT-0.37%SEIUSDT-3.91%IMXUSDT-3.85%GRTUSDT-3.34%WIFUSDT-5.38%OPUSDT-4.00%IOTAUSDT-4.12%POLUSDT-5.95%AXSUSDT-2.90%FARTCOINUSDT-3.37%EOSUSDT-0.93%DYDXUSDT-1.19%ORDIUSDT-1.43%GALAUSDT-5.34%NOTUSDT-2.97%RONINUSDT-2.64%NVDA-2.56%AAPL+2.09%GOOGL-0.15%MSFT+0.01%AMZN+0.07%TSM-1.00%SPCX+1.78%AVGO+0.04%META+0.01%TSLA-0.58%SKHY-4.03%MU-4.48%BRK-B-0.15%LLY+0.70%JPM-0.44%AMD-2.55%WMT+0.12%V-0.15%XOM+0.11%ASMLa-1.82%JNJ-0.04%INTC-4.41%MA-0.47%0700.HK-1.94%ORCL-2.24%1398.HK+0.79%BAC-0.50%ABBV+0.55%CSCO-0.53%CVX-0.46%COST+0.03%LRCX-3.93%KO+0.97%CAT-1.09%AMAT-2.32%0005.HK-0.78%AP2d-1.57%UNH-0.67%DELL-2.77%HSBA.L-1.17%MS-0.21%PG-0.22%GE-0.11%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.11%HD-0.96%GS-0.39%0939.HK+1.66%NZDJPY-2.69%AUDJPY-1.94%CHFJPY-1.66%USDJPY-1.50%NZDCAD-1.38%GBPJPY-1.38%EURJPY-1.37%EURNZD+1.37%CADJPY-1.32%GBPNZD+1.32%NZDUSD-1.22%NZDCHF-1.06%USDNOK+0.91%EURNOK+0.88%CHFNOK+0.80%AUDNZD+0.78%USDZAR+0.76%EURZAR+0.73%USDSEK+0.70%NOKJPY-0.68%EURSEK+0.66%GBPZAR+0.66%AUDCAD-0.65%AUDDKK-0.62%CHFSEK+0.59%EURAUD+0.58%GBPAUD+0.54%AUDSGD-0.49%USDMXN+0.46%AUDUSD-0.45%USDTHB+0.45%GBPTRY+0.41%NZDSGD-0.33%GBPHKD+0.32%CADCHF+0.32%AUDCHF-0.29%GBPMXN-0.28%EURCHF+0.28%AUDNOK+0.26%GBPCHF+0.26%USDPLN+0.25%EURPLN+0.21%USDCAD-0.17%USDCHF+0.17%USDILS+0.16%USDSGD+0.16%EURUSD+0.13%EURSGD+0.12%GBPUSD+0.11%USDTRY+0.11%EURCZK-0.08%GBPCAD-0.08%SGDJPY+0.08%USDCNH+0.06%NZDMXN-0.05%EURHKD-0.05%EURCAD-0.05%CHFSGD+0.04%EURCNH+0.04%USDCOP-0.04%EURGBP+0.04%USDDKK+0.04%GBPSGD+0.03%PLNJPY-0.01%USDHKD+0.01%EURDKK0.00%XPTUSD-4.93%HG1-4.65%GAGUSD-4.13%XAGUSD-4.13%UKOIL+3.72%USOIL+3.33%SUGAR+1.74%COCOA+1.05%GAUUSD-0.89%XAUUSD-0.89%S1+0.76%COTTON+0.71%BTCUSD-1.46%ETHUSD-1.30%USDTUSD-0.02%XRPUSD-2.93%SOLUSD-1.81%TRXUSDT-0.03%ZECUSDT-6.32%DOGEUSD-3.23%XMRUSDT-2.05%LINKUSD-1.53%XLMUSD-2.24%BCHUSDT-11.18%LTCUSD-2.07%UNIUSD-3.99%TONUSD+24.88%HBARUSDT-2.10%SUIUSD-3.84%TAOUSDT-5.84%AAVEUSD-3.26%DOTUSDT-3.07%ICPUSDT-1.15%ONDOUSDT-3.26%WLDUSDT-3.39%ATOMUSDT-4.43%ARBUSDT+0.43%JUPUSDT-3.82%INJUSDT-5.31%STXUSDT-3.80%FETUSDT-4.15%TIAUSDT-1.39%PYTHUSDT-0.37%SEIUSDT-3.91%IMXUSDT-3.85%GRTUSDT-3.34%WIFUSDT-5.38%OPUSDT-4.00%IOTAUSDT-4.12%POLUSDT-5.95%AXSUSDT-2.90%FARTCOINUSDT-3.37%EOSUSDT-0.93%DYDXUSDT-1.19%ORDIUSDT-1.43%GALAUSDT-5.34%NOTUSDT-2.97%RONINUSDT-2.64%
PM

Prime Medicine, Inc. (PRME)

NASDAQ • Healthcare

$3.47
-$0.08 (-2.5%)
Market open

Last close at September 9, 2026 at 20:00 UTC

Open$3.47
Previous Close$3.47
Day Range$3.29 - $3.54
Avg. Volume (3M)2.6M
Market Cap$626.7M
52 Week Range
$2.67$6.94
Next EarningsIn 57 daysNov 6, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$1.1M100%
Gross Profitminus cost of goods$1.1M100%

Fundamentals & Financials

Revenue (TTM)
$4M
Net Income (TTM)
-$187.8M
EPS (TTM)
-$1.1
ROA (TTM)
-75.45%
Current Ratio
3.05

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+12.0%Q1 2026-$0.22
-16.7%Q2 2026-$0.28
+6.7%Q3 2026-$0.24
Next

Nov 6

in 57 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About Prime Medicine, Inc.

Prime Medicine, Inc. is a NASDAQ-listed biotechnology company in healthcare that develops genetic therapies built on gene editing technology. The company is a small-cap biotech and has focused its platform on prime editing, a gene-writing approach aimed at making precise changes to DNA.

Name
Prime Medicine, Inc.
CEO
Allan Reine
Website
www.primemedicine.com
Industry
Healthcare
Year Founded
2019
Employees
146

Today's Snapshot

AI-generated

The session opened with PRME 2.9% lower at 3.37, while its sector was flat.

Trading Volume

Below 10d avg (2.4M)

673.3K

vs S&P 500 Today

Underperforming Market

-2.09%

Updated: September 10, 2026 at 15:06 UTC

Technical Indicators

1 Buy3 Neutral4 Sell
PRME shows a cautious sell bias as momentum indicators have softened while trend strength remains moderate. The stock trades below the short- and medium-term moving averages and beneath the 200-day averages, even as it sits near its 50- and 100-day SMAs, which suggests mixed intermediate structure. Momentum measures are weak and slightly negative while oscillator readings are neutral, and on-balance volume is negative, indicating distribution. Volatility is elevated relative to price, and the pivot sits just above the market. Technical takeaway: Sell.
All signals
  • EMA (5 indicators)$3.38 - $3.71
    Sell
  • RSI (14)48.74
    Neutral
  • Stochastic %K (14, 3, 3)41.67
    Neutral
  • MACD Level (12, 26)0.09
    Neutral

Peers & Related Assets

MRVIMaravai LifeSciences Holdings, Inc.
$6.95-3.3%
VIRVir Biotechnology, Inc.
$10.81-3.3%
SEPNSepterna Inc
$37.97+1.6%
BCAXBicara Therapeutics Inc. Common Stock
$23.64-0.3%
TYRATyra Biosciences, Inc.
$22.01-17.7%
REPLReplimune Group, Inc.
$14.45-2.2%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.